Development of Urologic Registry for Personalized Medicine in Patients With Urologic Malignant Diseases by Analyzing Microbiome

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Genitourinary malignancies such as prostate cancer, renal cell cancer, and bladder cancer in Korean population have been increased due to the aged population and the westernized lifestyles. With the advancement of technologies, studies have found that microbiome not only affects human physiological functions, such as metabolism, immunity, and haematopoiesis, but also plays a significant role in the development and progression of malignancies. However, the investigation of microbiome in urological malignances have been limited and few studies have been reported. Therefore, the investigator tried to evaluate the usefulness of microbiome in detection and monitoring of urological malignancies in Korean population. This study aims to use microbiome in tissue, plasma, stool and urine for the diagnosis, disease progression monitoring and therapeutic response evaluation. This study plan includes building big databases for microbiome of urological malignancies in Korean population.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 20
Healthy Volunteers: f
View:

• Patients diagnosed as urological malignancies (prostate cancer, renal cell cancer, bladder cancer, and ureter cancer)

• Patients who have undergone surgeries due to urological malignancies in Severance Hospital, Sinchon from 2020.10 and 2030.10

• Those who agree to give permission to use their human source information

• Those who agree with this study

Locations
Other Locations
Republic of Korea
Yonsei Severance Hospital
RECRUITING
Seoul
Contact Information
Primary
Won Sik Ham
uroham@yuhs.ac
82-02-2228-2310
Time Frame
Start Date: 2022-12-19
Estimated Completion Date: 2030-10
Participants
Target number of participants: 3000
Treatments
Prostate cancer
Patients diagnosed as prostate cancer and have undergone prostatectomy
Renal cell cancer
Patients diagnosed as renal cell cancer and have undergone partial or radical nephrectomy
Bladder cancer
Patients diagnosed as bladder cancer and have undergone radical or partial cystectomy
Ureter cancer
Patients diagnosed as ureter cancer and have undergone nephroureterectomy or ureterectomy
Sponsors
Leads: Yonsei University

This content was sourced from clinicaltrials.gov